These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 18600572)

  • 21. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragonomics: fragment-based drug discovery.
    Zartler ER; Shapiro MJ
    Curr Opin Chem Biol; 2005 Aug; 9(4):366-70. PubMed ID: 15925537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragment-based lead discovery: leads by design.
    Carr RA; Congreve M; Murray CW; Rees DC
    Drug Discov Today; 2005 Jul; 10(14):987-92. PubMed ID: 16023057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current topics in computer-aided drug design.
    Taft CA; Da Silva VB; Da Silva CH
    J Pharm Sci; 2008 Mar; 97(3):1089-98. PubMed ID: 18214973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural biology and drug discovery.
    Congreve M; Murray CW; Blundell TL
    Drug Discov Today; 2005 Jul; 10(13):895-907. PubMed ID: 15993809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated in silico tools for exploiting the natural products' bioactivity.
    Rollinger JM; Langer T; Stuppner H
    Planta Med; 2006 Jun; 72(8):671-8. PubMed ID: 16783689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating virtual screening in lead discovery.
    Oprea TI; Matter H
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-guided fragment screening for lead discovery.
    Verdonk ML; Hartshorn MJ
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP; Heyse S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico design of small molecules.
    Bernardo PH; Tong JC
    Methods Mol Biol; 2012; 800():25-31. PubMed ID: 21964780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in multivariate analysis in pharmaceutical process development.
    McKay B; Hoogenraad M; Damen EW; Smith AA
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):966-77. PubMed ID: 14758764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico functional profiling of small molecules and its applications.
    Sato T; Matsuo Y; Honma T; Yokoyama S
    J Med Chem; 2008 Dec; 51(24):7705-16. PubMed ID: 19032081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR-based approaches for lead discovery.
    Wyss DF; McCoy MA; Senior MM
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):630-47. PubMed ID: 12197321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.